Treatment of acute cerebral infarction with a choline precursor

Completed

Phase N/A Results

Summary of Purpose

To evaluate the safety and efficacy of cytidine 5'-diphosphocholine (CDP-choline) in patients with acute, moderate to severe cerebral infarction.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 May 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Prospective, randomized, double-blind, placebo-controlled study of 272 patients at 63 centers.

Contacts

Not available